Latest Norfloxacin Stories
Would Become First EMA-approved Therapy for Patients in Europe SUNNYVALE, Calif., May 22, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
The New "Mercy TAPE" Estimates Pediatric Weight with Greater Accuracy, Giving Doctors a Better Tool for Determining Prescription Dosage ROCKVILLE, Md., May 20, 2015 /PRNewswire/ --
- Following discussions with FDA, the Company plans to submit the Phase 2 study as one of two pivotal trials for NDA filing in 2016 NEWARK, N.J., May 6, 2015 /PRNewswire/ --
- SYM-1219, in late-stage clinical development, could be first single-dose oral treatment in the United States for the treatment of bacterial vaginosis (BV) - NEWARK, N.J., March 4, 2015 /PRNewswire/
DUBLIN, Jan. 6, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the U.S.
DUBLIN, Dec. 15, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it is filing an emergency appeal to the U.S.
RARITAN, N.J., Nov.
WASHINGTON, Oct. 14, 2014 /PRNewswire-USNewswire/ -- The following is a statement of Matthew L.
FDA marketing scrutiny no longer is limited to magazine and TV ads.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.